Kriegel I, Gertner J, Asselain B, Falcou M C, Le Queau F, Vedrenne J B
Institut Curie, Paris, France.
Pathol Biol (Paris). 1998 Jun;46(6):431-4.
Infections associated with central catheters are a significant source of morbidity in cancer patients. The first evaluation done as part of a continuous catheter surveillance program included the 913 central catheters inserted in 1995. Three of these catheters are still in place. All were tunneled subcutaneously, and most were inserted via the subclavian route. There were 839 simple silicone catheters and 74 catheters with a cuff. Two groups were defined based on whether the central catheter was inserted for administering inpatient or outpatient chemotherapy (n = 704) or for another reason (perioperative care, symptomatic or palliative therapy; n = 209). Catheter-related infection was defined as an infection at the catheter site or as septicemia retrospectively shown to be related to the catheter. The risk of catheter-related infection was expressed as the number of cases per 1000 days of catheterization. Reasons for catheter removal were distributed in table I.
与中心静脉导管相关的感染是癌症患者发病的一个重要原因。作为连续导管监测项目的一部分,首次评估纳入了1995年插入的913根中心静脉导管。其中3根导管仍在使用。所有导管均经皮下隧道置入,大多数通过锁骨下途径插入。有839根简单硅胶导管和74根带袖套导管。根据中心静脉导管插入是用于住院或门诊化疗(n = 704)还是用于其他原因(围手术期护理、对症或姑息治疗;n = 209)分为两组。导管相关感染定义为导管部位感染或回顾性显示与导管相关的败血症。导管相关感染的风险以每1000天导管插入的病例数表示。导管拔除原因分布在表I中。